Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-072387
Filing Date
2025-04-03
Accepted
2025-04-03 16:23:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d943530d424b3.htm 424B3 164197
2 GRAPHIC g943530g03g03.jpg GRAPHIC 44530
  Complete submission text file 0001193125-25-072387.txt   226591
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-286168 | Film No.: 25809839
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)